Protalix BioTherapeutics, Inc. Operating Income
Protalix BioTherapeutics, Inc. (PLX) reported Operating Income of $4.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was $4.67M, a 298.63% increase year-over-year.
- Protalix BioTherapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was $21.15M.
- Protalix BioTherapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$4.66M, a 164.61% decline year-over-year.
- Protalix BioTherapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was $2.13M, a 46.60% decline year-over-year.
- Protalix BioTherapeutics, Inc. operating income (loss) for fiscal 2025 was -$5.50M, a 240.41% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. operating income (loss) for fiscal 2024 was $3.92M, a 62.55% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. operating income (loss) for fiscal 2023 was $10.46M.
- Protalix BioTherapeutics, Inc. operating income (loss) for fiscal 2022 was -$13.01M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.67M 10-Q · filed 2026-08-12 | $25.82M 10-Q · filed 2026-08-12 | $21.16M derived: sum of 3 quarters · filed 2026-08-12 | $23.29M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $21.15M 10-Q · filed 2026-05-13 | $16.49M derived: sum of 2 quarters · filed 2026-05-13 | $18.62M derived: sum of 3 quarters · filed 2026-05-13 | $19.79M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$2.53M derived: sum of 2 quarters · filed 2026-03-18 | -$1.35M derived: sum of 3 quarters · filed 2026-08-12 | -$5.50M 10-K · filed 2026-03-18 | ||||
| 2025-09-30 | $2.13M 10-Q · filed 2025-11-13 | $3.30M derived: sum of 2 quarters · filed 2026-08-12 | -$842.00K 10-Q · filed 2025-11-13 | $6.37M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $1.17M 10-Q · filed 2026-08-12 | -$2.97M 10-Q · filed 2026-08-12 | $4.24M derived: sum of 3 quarters · filed 2026-08-12 | $8.23M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$4.14M 10-Q · filed 2026-05-13 | $3.06M derived: sum of 2 quarters · filed 2026-05-13 | $7.05M derived: sum of 3 quarters · filed 2026-05-13 | $4.63M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $7.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $11.20M derived: sum of 2 quarters · filed 2026-03-18 | $8.77M derived: sum of 3 quarters · filed 2026-03-18 | $3.92M 10-K · filed 2026-03-18 | ||||
| 2024-09-30 | $3.99M 10-Q · filed 2025-11-13 | $1.56M derived: sum of 2 quarters · filed 2025-11-13 | -$3.29M 10-Q · filed 2025-11-13 | -$8.91M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2024-06-30 | -$2.43M 10-Q · filed 2025-08-14 | -$7.28M 10-Q · filed 2025-08-14 | -$12.90M derived: sum of 3 quarters · filed 2026-03-18 | -$14.79M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2024-03-31 | -$4.86M 10-Q · filed 2025-05-09 | -$10.47M derived: sum of 2 quarters · filed 2026-03-18 | -$12.36M derived: sum of 3 quarters · filed 2026-03-18 | $8.06M derived: sum of 4 quarters · filed 2026-03-18 | ||||
| 2023-12-31 | -$5.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | -$7.50M derived: sum of 2 quarters · filed 2026-03-18 | $12.92M derived: sum of 3 quarters · filed 2026-03-18 | $10.46M 10-K · filed 2026-03-18 | ||||
| 2023-09-30 | -$1.89M 10-Q · filed 2024-11-14 | $18.53M derived: sum of 2 quarters · filed 2024-11-14 | $16.07M 10-Q · filed 2024-11-14 | $13.58M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-06-30 | $20.42M 10-Q · filed 2024-08-14 | $17.96M 10-Q · filed 2024-08-14 | $15.47M derived: sum of 3 quarters · filed 2025-03-17 | $12.34M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2023-03-31 | -$2.46M 10-Q · filed 2024-05-10 | -$4.95M derived: sum of 2 quarters · filed 2025-03-17 | -$8.08M derived: sum of 3 quarters · filed 2025-03-17 | -$13.60M derived: sum of 4 quarters · filed 2025-03-17 | ||||
| 2022-12-31 | -$2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$5.62M derived: sum of 2 quarters · filed 2025-03-17 | -$11.14M derived: sum of 3 quarters · filed 2025-03-17 | -$13.01M 10-K · filed 2025-03-17 | ||||
| 2022-09-30 | -$3.13M 10-Q · filed 2023-11-06 | -$8.65M derived: sum of 2 quarters · filed 2023-11-06 | -$10.52M 10-Q · filed 2023-11-06 | -$16.23M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | -$5.52M 10-Q · filed 2023-08-07 | -$7.39M 10-Q · filed 2023-08-07 | -$13.10M derived: sum of 3 quarters · filed 2024-03-14 | -$14.98M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | -$1.87M 10-Q · filed 2023-05-04 | -$7.58M derived: sum of 2 quarters · filed 2024-03-14 | -$9.46M derived: sum of 3 quarters · filed 2024-03-14 | -$18.63M derived: sum of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$7.59M derived: sum of 2 quarters · filed 2024-03-14 | -$16.76M derived: sum of 3 quarters · filed 2024-03-14 | -$20.46M 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | -$1.89M 10-Q · filed 2022-11-14 | -$11.05M derived: sum of 2 quarters · filed 2022-11-14 | -$14.76M 10-Q · filed 2022-11-14 | -$11.92M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-06-30 | -$9.17M 10-Q · filed 2022-08-15 | -$12.87M 10-Q · filed 2022-08-15 | -$10.03M derived: sum of 3 quarters · filed 2023-02-27 | -$12.61M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2021-03-31 | -$3.71M 10-Q · filed 2022-05-16 | -$866.00K derived: sum of 2 quarters · filed 2023-02-27 | -$3.45M derived: sum of 3 quarters · filed 2023-02-27 | -$5.69M derived: sum of 4 quarters · filed 2023-02-27 | ||||
| 2020-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $257.00K derived: sum of 2 quarters · filed 2023-02-27 | -$1.98M derived: sum of 3 quarters · filed 2023-02-27 | $2.71M 10-K · filed 2023-02-27 | ||||
| 2020-09-30 | -$2.58M 10-Q · filed 2021-11-15 | -$4.82M derived: sum of 2 quarters · filed 2021-11-15 | -$129.00K 10-Q · filed 2021-11-15 | $2.07M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$2.24M 10-Q · filed 2021-08-16 | $2.45M 10-Q · filed 2021-08-16 | $4.65M derived: sum of 3 quarters · filed 2021-08-16 | $3.11M derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $4.69M 10-Q · filed 2021-05-14 | $6.89M derived: sum of 2 quarters · filed 2021-05-14 | $5.35M derived: sum of 3 quarters · filed 2021-05-14 | -$490.00K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | $2.20M 10-K · filed 2020-03-12 | $656.00K derived: sum of 2 quarters · filed 2020-10-29 | -$5.18M derived: sum of 3 quarters · filed 2020-10-29 | -$10.72M 10-K · filed 2022-03-31 | ||||
| 2019-09-30 | -$1.54M 10-Q · filed 2020-10-29 | -$7.38M derived: sum of 2 quarters · filed 2020-10-29 | -$12.92M 10-Q · filed 2020-10-29 | -$16.59M derived: sum of 4 quarters · filed 2020-10-29 | ||||
| 2019-06-30 | -$5.84M 10-Q · filed 2020-08-10 | -$11.37M 10-Q · filed 2020-08-10 | -$15.04M derived: sum of 3 quarters · filed 2020-08-10 | -$18.79M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$5.53M 10-Q · filed 2020-06-01 | -$9.21M derived: sum of 2 quarters · filed 2020-06-01 | -$12.95M derived: sum of 3 quarters · filed 2020-06-01 | -$19.69M derived: sum of 4 quarters · filed 2020-06-01 | ||||
| 2018-12-31 | -$3.67M 10-K · filed 2020-03-12 | -$7.41M derived: sum of 2 quarters · filed 2020-03-12 | -$14.16M derived: sum of 3 quarters · filed 2020-03-12 | -$19.31M 10-K · filed 2021-03-30 | ||||
| 2018-09-30 | -$3.74M 10-K · filed 2020-03-12 | -$13.96M 10-Q · filed 2018-11-07 | -$10.48M derived: sum of 2 quarters · filed 2020-03-12 | -$15.64M 10-Q · filed 2019-11-07 | -$30.85M 10-Q · filed 2018-11-07 | -$25.22M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-06-30 | -$6.74M 10-K · filed 2020-03-12 | -$9.58M 10-Q · filed 2018-08-09 | -$11.89M 10-Q · filed 2019-08-08 | -$16.89M 10-Q · filed 2018-08-09 | -$21.48M derived: sum of 3 quarters · filed 2020-03-12 | -$29.24M derived: sum of 4 quarters · filed 2020-03-12 | ||
| 2018-03-31 | -$5.15M 10-K · filed 2020-03-12 | -$7.31M 10-Q · filed 2018-05-09 | -$14.73M derived: sum of 2 quarters · filed 2020-03-12 | -$22.50M derived: sum of 3 quarters · filed 2020-03-12 | -$33.30M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | -$9.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | -$17.35M derived: sum of 2 quarters · filed 2020-03-12 | -$28.15M derived: sum of 3 quarters · filed 2020-03-12 | -$34.52M 10-K · filed 2020-03-12 | -$36.35M 10-K · filed 2018-03-06 | |||
| 2017-09-30 | -$7.76M 10-Q · filed 2019-03-18 | -$18.57M derived: sum of 2 quarters · filed 2019-03-18 | -$24.93M 10-Q · filed 2019-03-18 | -$33.66M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-06-30 | -$10.80M 10-Q · filed 2019-03-18 | -$17.17M 10-Q · filed 2019-03-18 | -$25.89M derived: sum of 3 quarters · filed 2019-03-18 | -$32.54M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2017-03-31 | -$6.37M 10-Q · filed 2019-03-18 | -$15.09M derived: sum of 2 quarters · filed 2019-03-18 | -$21.73M derived: sum of 3 quarters · filed 2019-03-18 | -$31.66M derived: sum of 4 quarters · filed 2019-03-18 | ||||
| 2016-12-31 | -$8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$15.37M derived: sum of 2 quarters · filed 2019-03-18 | -$25.30M derived: sum of 3 quarters · filed 2019-03-18 | -$33.16M 10-K · filed 2019-03-18 | ||||
| 2016-09-30 | -$6.65M 10-Q · filed 2017-11-08 | -$16.58M derived: sum of 2 quarters · filed 2017-11-08 | -$24.44M 10-Q · filed 2017-11-08 | -$32.14M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-06-30 | -$9.93M 10-Q · filed 2017-08-09 | -$17.80M 10-Q · filed 2017-08-09 | -$25.50M derived: sum of 3 quarters · filed 2018-03-06 | -$30.50M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2016-03-31 | -$7.86M 10-Q · filed 2017-05-10 | -$15.56M derived: sum of 2 quarters · filed 2018-03-06 | -$20.57M derived: sum of 3 quarters · filed 2018-03-06 | -$26.15M derived: sum of 4 quarters · filed 2018-03-06 | ||||
| 2015-12-31 | -$7.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | -$12.70M derived: sum of 2 quarters · filed 2018-03-06 | -$18.29M derived: sum of 3 quarters · filed 2018-03-06 | -$23.67M 10-K · filed 2018-03-06 | ||||
| 2015-09-30 | -$5.00M 10-Q · filed 2016-11-09 | -$2.81M 10-Q · filed 2015-11-09 | -$10.59M derived: sum of 2 quarters · filed 2016-11-09 | -$15.97M 10-Q · filed 2016-11-09 | -$12.12M 10-Q · filed 2015-11-09 | -$26.41M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | -$5.58M 10-Q · filed 2016-08-08 | -$4.47M 10-Q · filed 2015-08-10 | -$10.97M 10-Q · filed 2016-08-08 | -$9.31M 10-Q · filed 2015-08-10 | -$21.40M derived: sum of 3 quarters · filed 2017-03-16 | -$27.61M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | -$5.38M 10-Q · filed 2016-05-09 | -$4.84M 10-Q · filed 2015-05-07 | -$15.82M derived: sum of 2 quarters · filed 2017-03-16 | -$22.03M derived: sum of 3 quarters · filed 2017-03-16 | -$27.48M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2014-12-31 | -$10.44M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$16.64M derived: sum of 2 quarters · filed 2017-03-16 | -$22.09M derived: sum of 3 quarters · filed 2017-03-16 | -$28.56M 10-K · filed 2017-03-16 | -$25.20M 10-K · filed 2015-03-12 | |||
| 2014-09-30 | -$6.21M 10-Q · filed 2015-11-09 | -$11.65M derived: sum of 2 quarters · filed 2015-11-09 | -$18.12M 10-Q · filed 2015-11-09 | -$35.22M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-06-30 | -$5.45M 10-Q · filed 2015-08-10 | -$11.91M 10-Q · filed 2015-08-10 | -$29.01M derived: sum of 3 quarters · filed 2016-03-08 | -$34.66M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2014-03-31 | -$6.47M 10-Q · filed 2015-05-07 | -$23.56M derived: sum of 2 quarters · filed 2016-03-08 | -$29.21M derived: sum of 3 quarters · filed 2016-03-08 | -$36.10M derived: sum of 4 quarters · filed 2016-03-08 | ||||
| 2013-12-31 | -$17.09M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$22.74M derived: sum of 2 quarters · filed 2016-03-08 | -$29.63M derived: sum of 3 quarters · filed 2016-03-08 | -$34.06M 10-K · filed 2016-03-08 | -$27.12M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | -$5.64M 10-Q · filed 2014-11-10 | -$12.54M derived: sum of 2 quarters · filed 2014-11-10 | -$16.97M 10-Q · filed 2014-11-10 | -$27.14M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-06-30 | -$6.89M 10-Q · filed 2014-08-07 | -$11.32M 10-Q · filed 2014-08-07 | -$21.49M derived: sum of 3 quarters · filed 2015-03-12 | -$27.05M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2013-03-31 | -$4.43M 10-Q · filed 2014-05-08 | -$14.60M derived: sum of 2 quarters · filed 2015-03-12 | -$20.16M derived: sum of 3 quarters · filed 2015-03-12 | -$10.54M derived: sum of 4 quarters · filed 2015-03-12 | ||||
| 2012-12-31 | -$10.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$15.73M derived: sum of 2 quarters · filed 2015-03-12 | -$6.11M derived: sum of 3 quarters · filed 2015-03-12 | -$12.17M 10-K · filed 2015-03-12 | ||||
| 2012-09-30 | -$5.56M 10-Q · filed 2013-11-07 | $4.06M derived: sum of 2 quarters · filed 2013-11-07 | -$2.00M 10-Q · filed 2013-11-07 | -$10.86M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-06-30 | $9.62M 10-Q · filed 2013-08-08 | $3.56M 10-Q · filed 2013-08-08 | -$5.30M derived: sum of 3 quarters · filed 2014-03-13 | -$14.07M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2012-03-31 | -$6.07M 10-Q · filed 2013-05-09 | -$14.92M derived: sum of 2 quarters · filed 2014-03-13 | -$23.69M derived: sum of 3 quarters · filed 2014-03-13 | -$37.56M derived: sum of 4 quarters · filed 2014-03-13 | ||||
| 2011-12-31 | -$8.86M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$17.63M derived: sum of 2 quarters · filed 2014-03-13 | -$31.49M derived: sum of 3 quarters · filed 2014-03-13 | -$36.53M 10-K · filed 2014-03-13 | ||||
| 2011-09-30 | -$8.77M 10-Q · filed 2012-11-07 | -$22.64M derived: sum of 2 quarters · filed 2012-11-07 | -$27.67M 10-Q · filed 2012-11-07 | -$36.52M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | -$13.87M 10-Q · filed 2012-08-03 | -$18.91M 10-Q · filed 2012-08-03 | -$27.75M derived: sum of 3 quarters · filed 2013-02-28 | -$30.60M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | -$5.04M 10-Q · filed 2012-05-09 | -$13.89M derived: sum of 2 quarters · filed 2013-02-28 | -$16.73M derived: sum of 3 quarters · filed 2013-02-28 | -$26.88M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$8.85M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$11.70M derived: sum of 2 quarters · filed 2013-02-28 | -$21.85M derived: sum of 3 quarters · filed 2013-02-28 | -$29.97M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | -$2.85M 10-Q · filed 2011-11-07 | -$13.00M derived: sum of 2 quarters · filed 2011-11-07 | -$21.12M 10-Q · filed 2011-11-07 | |||||
| 2010-06-30 | -$10.15M 10-Q · filed 2011-08-08 | -$18.27M 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | -$31.97M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |